0001まそ ★
2020/11/11(水) 20:26:59.02ID:YwY/1FsA9Pfizer chief executive Albert Bourla sold 62% of his stock in the company on the same day the drugmaker announced the results of its COVID-19 vaccine trial.
Bourla sold $5.6 million in stock on Monday as part of a predetermined trading plan adopted on August 19.
His stock sale was carried out at $41.94 a share. The 52-week-high for Pfizer stock is $41.99, which means the CEO cashed out his shares close to their highest this year.
Pfizer and its German partner BioNTech are the first to post positive results from pivotal COVID-19 vaccine trials.
https://markets.businessinsider.com/news/stocks/pfizer-ceo-sold-stock-day-covid-19-vaccine-results-unveiled-2020-11-1029790705